NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









FerroptoCure Inc.

FerroptoCure Inc.

Private
TokyoHealthcare & Life Scienceshttps://ferroptocure.com/

Last Round

Series A

Sep 19, 2025

Total Funding Raised

$6.91M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

FerroptoCure Inc. is a biotechnology company developing therapeutic drugs designed to control ferroptosis for the treatment of cancer, neurodegenerative disorders, and other diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

ferroptosisferroptosis induceranticancer drugstreatment-resistant cancersmall molecule drugsclinical stage biopharmaoncologyTriple-Negative Breast CancerTNBCrefractory cancerdrug repurposingoral anticancer drugssolid tumorsdrug discoverypharma licensingcompanion animal healthneurodegenerative diseases

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

FerroptoCure Inc. Comps

Public and private peers based on sector, stage, and business model.

FerroptoCure Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

FerroptoCure Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 19, 2025
SeedJun 5, 2023

FerroptoCure Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 7, 2025

    Monthly visitors increased 234% MoM, reaching 6K.

  • Sep 19, 2025

    $3M round with ANRI株式会社 and Diamond Medino Capital

FerroptoCure Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

FerroptoCure Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about FerroptoCure Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo
Employee Range2
Year Founded2022
Last FundingSep 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.